Jaison James is a pharmacist who is specialized in Ambulatory Care in New York, New York. Patients can reach him at 425 E 67th St, New York or contact him on 845-598-6177. Active license number of Jaison James is 069289 for Ambulatory Care in New York. Jaison James is a licensed pharmacist who has demonstrated specialized knowledge and skill in the provision of integrated, accessible health care services by pharmacists and is accountable for addressing medication needs, developing sustained partnerships with patients, and practicing in the context of family and community.
Complete Profile:
Jaison James speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Jaison James
Specialization:
Ambulatory Care
Gender:
Male
Location:
425 E 67th St, New York, New York, 10065-6004
Phone:
845-598-6177
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Jaison James are as mentioned below.
NPI Number:
1346059821
NPI Enumeration Date:
30 Dec, 2024
NPI Last Update On:
30 Dec, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Jaison James are as mentioned below.
Specialization
License Number
State
Status
Ambulatory Care
069289
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
33 Scher Dr, New City, New York
Zip:
10956-6436
Phone Number:
845-598-6177
Fax Number:
--
Patients can reach Jaison James at 425 E 67th St, New York, New York or can call on phone at 845-598-6177.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.